2 drug(s) with this reaction
1,863 total reports
Infusion Related Reaction has been reported as an adverse reaction across 2 drug(s) manufactured by Chattem Inc in the FDA Adverse Event Reporting System (FAERS) database. A combined total of 1,863 adverse event reports mention infusion related reaction in connection with Chattem Inc products.
This page provides a breakdown of which Chattem Inc drugs are most commonly associated with infusion related reaction, along with report counts and links to detailed safety analyses for each medication. Understanding which drugs from a single manufacturer share a common adverse reaction can help patients and healthcare providers identify potential class-wide safety patterns.
The following Chattem Inc drugs have infusion related reaction listed in their FDA adverse event reports, sorted by report count:
In addition to infusion related reaction, the following adverse reactions have been reported across Chattem Inc's drug portfolio:
2 drug(s) manufactured by Chattem Inc have infusion related reaction listed in their FDA adverse event reports: TRIAMCINOLONE ACETONIDE, LIDOCAINE, MENTHOL.
There are a combined 1,863 reports of infusion related reaction across 2 Chattem Inc drug(s) in the FDA adverse event database.